US 12421316
Bispecific immunotoxins targeting human CD25+CCR4+ tumors and regulatory T-cells
granted A61KA61K45/06A61P
Quick answer
US patent 12421316 (Bispecific immunotoxins targeting human CD25+CCR4+ tumors and regulatory T-cells) held by The Regents of the University of Colorado, a Body Corporate expires Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Regents of the University of Colorado, a Body Corporate
- Grant date
- Tue Sep 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Sep 18 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K45/06, A61P, A61P35/00